7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-06-30 2015-09-30 2013-09-30 2013-06-30 2012-09-30 2012-06-30 
      
    		                                         
      assets
    		                                         
      current assets:
    		                                         
      cash and cash equivalents
    		1,308,000,000 1,727,000,000 1,134,000,000 1,181,000,000 719,000,000 595,000,000 733,000,000 947,000,000 760,000,000 579,000,000 518,000,000 564,000,000 486,000,000 659,000,000 1,249,000,000 582,000,000 690,000,000 642,000,000 679,000,000 605,000,000 977,000,000 896,000,000 912,000,000 3,243,000,000 825,000,000 878,000,000 782,000,000 721,000,000 973,000,000 838,000,000 909,000,000 720,000,000 964,000,000 1,214,000,000 1,210,000,000 852,400,000 1,420,000,000 596,347,000 2,539,390,000 257,730,000 395,266,000 
      restricted cash
    		32,000,000 16,000,000 23,000,000 20,000,000 31,000,000 28,000,000 22,000,000  20,000,000 9,000,000 13,000,000      1,214,000,000 1,214,000,000 1,214,000,000 1,211,000,000 1,011,000,000 1,011,000,000 1,011,000,000 1,000,000 2,000,000 2,000,000 2,000,000 2,000,000    77,000,000 928,000,000 811,000,000      8,231,000 8,598,000 
      trade receivables
    		2,417,000,000 2,210,000,000 2,072,000,000 2,140,000,000 2,094,000,000 2,102,000,000 2,048,000,000 1,998,000,000 1,948,000,000 1,743,000,000 1,688,000,000 1,790,000,000 1,739,000,000 1,645,000,000 1,566,000,000 1,775,000,000 1,730,000,000 1,609,000,000 1,499,000,000 1,577,000,000 1,733,000,000 1,369,000,000 1,712,000,000 1,839,000,000 1,747,000,000 1,829,000,000 1,786,000,000 1,865,000,000 2,041,000,000 1,973,000,000 1,940,000,000 2,130,000,000 2,229,000,000 2,096,000,000 2,097,000,000 2,732,500,000 2,696,300,000     
      inventories
    		1,598,000,000 1,655,000,000 1,613,000,000 1,595,000,000 1,655,000,000 1,612,000,000 1,636,000,000 1,544,000,000 1,272,000,000 1,240,000,000 1,222,000,000 1,090,000,000 1,056,000,000 1,073,000,000 1,045,000,000 993,000,000 1,058,000,000 1,086,000,000 1,076,000,000 1,094,000,000 1,224,000,000 1,226,000,000 1,124,000,000 1,107,000,000 1,100,000,000 1,060,000,000 1,012,000,000 934,000,000 971,000,000 993,000,000 1,042,000,000 1,048,000,000 1,071,000,000 1,084,000,000 1,111,000,000 1,336,700,000 1,199,200,000 1,076,088,000 497,059,000 418,252,000 388,729,000 
      prepaid expenses and other current assets
    		894,000,000 906,000,000 890,000,000 838,000,000 852,000,000 874,000,000 957,000,000 1,092,000,000 1,048,000,000 890,000,000 796,000,000 776,000,000 718,000,000 820,000,000 765,000,000 720,000,000 632,000,000 899,000,000 924,000,000 855,000,000 726,000,000 776,000,000 745,000,000 779,000,000 631,000,000 698,000,000 693,000,000 689,000,000 757,000,000 835,000,000 833,000,000 771,000,000 736,000,000 710,000,000 675,000,000 896,800,000 953,000,000 257,389,000 115,497,000 72,214,000 56,470,000 
      total current assets
    		6,249,000,000 6,514,000,000 5,732,000,000 5,774,000,000 5,351,000,000 5,211,000,000 5,396,000,000 5,596,000,000 5,048,000,000 4,461,000,000 4,237,000,000 4,247,000,000 4,010,000,000 5,417,000,000 5,836,000,000 5,607,000,000 5,324,000,000 5,450,000,000 5,392,000,000 5,342,000,000 5,671,000,000 5,278,000,000 5,504,000,000 6,969,000,000 4,305,000,000 4,467,000,000 4,275,000,000 4,211,000,000 4,742,000,000 4,639,000,000 4,724,000,000 4,746,000,000 5,944,000,000 5,992,000,000 5,333,000,000 5,818,400,000 6,995,700,000 3,848,363,000 4,532,026,000 1,713,670,000 1,630,234,000 
      property, plant and equipment
    		2,026,000,000 1,994,000,000 1,882,000,000 1,780,000,000 1,789,000,000 1,738,000,000 1,713,000,000 1,707,000,000 1,584,000,000 1,599,000,000 1,596,000,000 1,600,000,000 1,507,000,000 1,545,000,000 1,579,000,000 1,598,000,000 1,584,000,000 1,590,000,000 1,556,000,000 1,567,000,000 1,550,000,000 1,496,000,000 1,450,000,000 1,466,000,000 1,390,000,000 1,372,000,000 1,341,000,000 1,353,000,000 1,341,000,000 1,355,000,000 1,411,000,000 1,403,000,000 1,398,000,000 1,373,000,000 1,328,000,000 1,472,100,000 1,351,400,000 1,221,606,000 440,998,000 450,327,000 409,399,000 
      intangible assets
    		4,830,000,000 5,047,000,000 5,297,000,000 5,551,000,000 5,652,000,000 5,903,000,000 6,183,000,000 6,456,000,000 6,728,000,000 5,299,000,000 5,552,000,000 5,800,000,000 6,024,000,000 6,322,000,000 6,632,000,000 6,948,000,000 7,258,000,000 7,624,000,000 7,997,000,000 8,445,000,000 8,923,000,000 9,297,000,000 9,726,000,000 10,201,000,000 10,650,000,000 11,196,000,000 11,683,000,000 12,001,000,000 12,655,000,000 13,393,000,000 14,464,000,000 15,211,000,000 16,023,000,000 17,516,000,000 18,186,000,000 21,335,800,000 22,382,100,000 13,090,339,000 9,289,669,000 8,035,717,000 8,121,556,000 
      goodwill
    		11,287,000,000 11,298,000,000 11,153,000,000 11,087,000,000 11,171,000,000 11,127,000,000 11,160,000,000 11,183,000,000 11,187,000,000 11,628,000,000 11,579,000,000 11,547,000,000 12,044,000,000 12,266,000,000 12,427,000,000 12,457,000,000 12,477,000,000 12,527,000,000 12,485,000,000 13,044,000,000 13,160,000,000 13,084,000,000 13,034,000,000 13,126,000,000 13,052,000,000 13,160,000,000 13,121,000,000 13,142,000,000 13,290,000,000 13,283,000,000 13,432,000,000 15,593,000,000 15,573,000,000 15,892,000,000 15,753,000,000 18,511,800,000 17,374,700,000 9,742,003,000 5,277,798,000 3,799,613,000 3,724,341,000 
      deferred tax assets
    		2,050,000,000 2,025,000,000 1,977,000,000 1,968,000,000 2,188,000,000 2,187,000,000 2,149,000,000 2,101,000,000 2,189,000,000 2,191,000,000 2,163,000,000 2,166,000,000 2,372,000,000 2,283,000,000 2,282,000,000 2,252,000,000 2,266,000,000 2,255,000,000 2,150,000,000 2,137,000,000 1,913,000,000 1,874,000,000 1,740,000,000 1,690,000,000 1,868,000,000 1,799,000,000 1,754,000,000 1,676,000,000 1,641,000,000 1,654,000,000 1,660,000,000 433,000,000 166,000,000 140,000,000 142,000,000 304,700,000 727,200,000 221,934,000 198,674,000 150,539,000 150,362,000 
      other non-current assets
    		382,000,000 388,000,000 380,000,000 363,000,000 389,000,000 329,000,000 312,000,000 307,000,000 328,000,000 325,000,000 318,000,000 326,000,000 341,000,000 338,000,000 334,000,000 340,000,000 343,000,000 596,000,000 617,000,000 664,000,000 345,000,000 367,000,000 411,000,000 411,000,000 402,000,000 360,000,000 377,000,000 109,000,000 108,000,000 124,000,000 107,000,000 99,000,000 152,000,000 111,000,000 190,000,000       
      total assets
    		26,824,000,000 27,266,000,000 26,421,000,000 26,523,000,000 26,540,000,000 26,495,000,000 26,913,000,000 27,350,000,000 27,064,000,000 25,503,000,000 25,445,000,000 25,686,000,000 26,298,000,000 28,171,000,000 29,090,000,000 29,202,000,000 29,252,000,000 30,042,000,000 30,197,000,000 31,199,000,000 31,562,000,000 31,396,000,000 31,865,000,000 33,863,000,000 31,667,000,000 32,354,000,000 32,551,000,000 32,492,000,000 33,777,000,000 34,448,000,000 35,798,000,000 37,497,000,000 39,974,000,000 41,733,000,000 42,333,000,000 47,662,200,000 48,454,600,000 28,204,384,000 19,782,258,000 14,146,208,000 14,019,820,000 
      liabilities
    		                                         
      current liabilities:
    		                                         
      accounts payable
    		616,000,000 627,000,000 620,000,000 656,000,000 667,000,000 579,000,000 642,000,000 719,000,000 569,000,000 515,000,000 561,000,000 521,000,000 486,000,000 536,000,000 471,000,000 407,000,000 455,000,000 442,000,000 342,000,000 337,000,000 379,000,000 447,000,000 444,000,000 503,000,000 437,000,000 527,000,000 429,000,000 411,000,000 440,000,000 417,000,000 428,000,000 365,000,000 407,000,000 371,000,000 368,000,000 425,900,000 476,800,000 412,943,000 284,544,000 166,688,000 156,178,000 
      accrued and other current liabilities
    		3,598,000,000 3,469,000,000 3,354,000,000 3,422,000,000 3,386,000,000 3,338,000,000 3,225,000,000 3,133,000,000 3,119,000,000 3,008,000,000 2,916,000,000 2,988,000,000 2,934,000,000 4,311,000,000 4,303,000,000 4,791,000,000 4,982,000,000 5,075,000,000 4,556,000,000 4,576,000,000 4,353,000,000 4,270,000,000 4,438,000,000 4,511,000,000 3,198,000,000 3,122,000,000 3,255,000,000 3,197,000,000 3,424,000,000 3,427,000,000 3,560,000,000 3,694,000,000 3,396,000,000 3,259,000,000 3,484,000,000 3,335,500,000 3,293,500,000     
      current portion of long-term debt
    		579,000,000 879,000,000 282,000,000 2,674,000,000 453,000,000 452,000,000 538,000,000 450,000,000 536,000,000 444,000,000 446,000,000 432,000,000 411,000,000 150,000,000                     346,000,000 294,100,000 707,000,000 360,964,000 346,875,000 207,688,000 195,154,000 
      total current liabilities
    		4,793,000,000 4,975,000,000 4,256,000,000 6,752,000,000 4,506,000,000 4,369,000,000 4,405,000,000 4,302,000,000 4,224,000,000 3,967,000,000 3,923,000,000 3,941,000,000 3,831,000,000 4,997,000,000 4,774,000,000 5,198,000,000 5,437,000,000 5,517,000,000 4,898,000,000 4,913,000,000 4,732,000,000 4,718,000,000 4,886,000,000 6,248,000,000 3,735,000,000 3,705,000,000 3,941,000,000 3,836,000,000 4,162,000,000 4,074,000,000 3,990,000,000 4,268,000,000 4,728,000,000 4,465,000,000 4,247,000,000 4,226,400,000 4,650,500,000 2,853,082,000 1,761,818,000 1,158,508,000 1,049,197,000 
      acquisition-related contingent consideration
    		224,000,000 264,000,000 282,000,000 310,000,000 248,000,000 230,000,000 225,000,000 253,000,000 247,000,000 197,000,000 219,000,000 208,000,000 189,000,000 188,000,000 193,000,000 202,000,000 207,000,000 206,000,000 202,000,000 216,000,000 275,000,000 279,000,000 268,000,000 262,000,000 267,000,000 271,000,000 264,000,000 298,000,000 282,000,000 310,000,000 320,000,000 344,000,000 345,000,000 755,000,000 818,000,000 170,900,000 161,600,000 125,524,000 91,029,000 112,274,000 67,115,000 
      non-current portion of long-term debt
    		20,463,000,000 20,859,000,000 21,228,000,000 18,942,000,000 21,054,000,000 21,208,000,000 21,536,000,000 21,938,000,000 21,894,000,000 20,108,000,000 20,207,000,000 20,334,000,000 20,804,000,000 21,664,000,000 23,168,000,000 22,654,000,000 22,358,000,000 23,439,000,000 23,738,000,000 23,925,000,000 24,343,000,000 24,357,000,000 24,424,000,000 24,661,000,000 23,466,000,000 24,023,000,000 23,924,000,000 24,077,000,000 24,433,000,000 24,858,000,000 25,266,000,000 25,235,000,000 26,216,000,000 27,648,000,000 28,198,000,000       
      deferred tax liabilities
    		145,000,000 144,000,000 134,000,000 128,000,000 169,000,000 170,000,000 170,000,000 163,000,000 213,000,000 215,000,000 205,000,000 202,000,000 422,000,000 545,000,000 552,000,000 529,000,000 513,000,000 516,000,000 520,000,000 528,000,000 650,000,000 694,000,000 690,000,000 705,000,000 879,000,000 884,000,000 880,000,000 885,000,000 1,131,000,000 1,130,000,000 1,139,000,000 1,180,000,000 2,237,000,000 4,273,000,000 4,490,000,000 5,879,200,000 11,600,000 64,191,000 4,363,000 8,786,000 7,525,000 
      other non-current liabilities
    		843,000,000 877,000,000 761,000,000 713,000,000 805,000,000 745,000,000 751,000,000 776,000,000 721,000,000 745,000,000 746,000,000 741,000,000 619,000,000 524,000,000 544,000,000 653,000,000 872,000,000 975,000,000 963,000,000 1,012,000,000 907,000,000 802,000,000 807,000,000 851,000,000 760,000,000 783,000,000 763,000,000 581,000,000 532,000,000 518,000,000 560,000,000 526,000,000 102,000,000 104,000,000 88,000,000       
      total liabilities
    		26,468,000,000 27,119,000,000 26,661,000,000 26,845,000,000 26,782,000,000 26,722,000,000 27,087,000,000 27,432,000,000 27,299,000,000 25,232,000,000 25,300,000,000 25,426,000,000 25,865,000,000 27,918,000,000 29,231,000,000 29,236,000,000 29,387,000,000 30,653,000,000 30,321,000,000 30,594,000,000 30,907,000,000 30,850,000,000 31,075,000,000 32,727,000,000 29,107,000,000 29,666,000,000 29,772,000,000 29,677,000,000 30,540,000,000 30,890,000,000 31,275,000,000 31,553,000,000 34,552,000,000 37,704,000,000 38,339,000,000 42,259,100,000 41,989,900,000 23,143,194,000 14,079,729,000 10,361,026,000 10,324,389,000 
      commitments and contingencies
    		                                         
      equity
    		                                         
      common shares, no par value, unlimited shares authorized, 370,473,221 and 367,843,058 issued and outstanding at september 30, 2025 and december 31, 2024, respectively
    		10,515,000,000                                         
      additional paid-in capital
    		275,000,000 250,000,000 220,000,000 234,000,000 201,000,000 181,000,000 164,000,000 214,000,000 190,000,000 188,000,000 171,000,000 159,000,000 129,000,000 104,000,000 415,000,000 462,000,000 437,000,000 413,000,000 393,000,000 454,000,000 435,000,000 411,000,000 396,000,000 429,000,000 406,000,000 384,000,000 374,000,000 413,000,000 409,000,000 391,000,000 382,000,000 380,000,000 368,000,000 350,000,000 374,000,000 380,400,000 244,600,000 251,654,000 225,289,000 270,183,000 283,061,000 
      accumulated deficit
    		-9,555,000,000 -9,734,000,000 -9,882,000,000 -9,824,000,000 -9,917,000,000 -9,832,000,000 -9,842,000,000 -9,778,000,000 -9,739,000,000 -9,361,000,000 -9,387,000,000 -9,186,000,000 -8,776,000,000 -9,175,000,000 -9,030,000,000 -8,961,000,000 -9,030,000,000 -9,218,000,000 -8,623,000,000 -8,013,000,000 -7,860,000,000 -7,931,000,000 -7,605,000,000 -7,452,000,000 -5,936,000,000 -5,887,000,000 -5,716,000,000 -5,664,000,000 -5,320,000,000 -4,970,000,000 -4,209,000,000 -2,725,000,000 -3,239,000,000 -4,539,000,000 -4,502,000,000 -3,425,700,000 -2,338,500,000 -3,402,294,000 -2,429,051,000 -2,281,834,000 -2,245,886,000 
      accumulated other comprehensive loss
    		-1,800,000,000 -1,790,000,000 -2,029,000,000 -2,179,000,000 -1,947,000,000 -2,007,000,000 -1,917,000,000 -1,881,000,000 -2,051,000,000 -1,902,000,000 -1,989,000,000 -2,056,000,000 -2,265,000,000 -2,002,000,000 -1,974,000,000 -1,924,000,000 -1,923,000,000 -2,182,000,000 -2,256,000,000 -2,133,000,000 -2,207,000,000 -2,223,000,000 -2,281,000,000 -2,086,000,000 -2,156,000,000 -2,061,000,000 -2,116,000,000 -2,137,000,000 -2,053,000,000 -2,068,000,000 -1,852,000,000 -1,896,000,000 -1,888,000,000 -1,965,000,000 -2,020,000,000 -1,573,700,000 -1,463,400,000 -160,257,000 -343,901,000 -119,838,000 -226,969,000 
      total bausch health companies inc. shareholders’ deficit
    		-565,000,000 -764,000,000 -1,183,000,000 -1,279,000,000 -1,174,000,000 -1,175,000,000 -1,115,000,000 -1,022,000,000 -1,180,000,000 -663,000,000 -800,000,000 -692,000,000 -525,000,000 -693,000,000 -216,000,000                           
      noncontrolling interest
    		921,000,000 911,000,000 943,000,000 957,000,000 932,000,000 948,000,000 941,000,000 940,000,000 945,000,000 934,000,000 945,000,000 952,000,000 958,000,000 946,000,000 75,000,000 72,000,000 69,000,000 76,000,000 73,000,000 70,000,000 68,000,000 72,000,000 71,000,000 73,000,000 78,000,000 87,000,000 86,000,000 82,000,000 84,000,000 91,000,000 99,000,000 95,000,000 95,000,000 98,000,000 101,000,000 107,200,000 122,400,000 112,077,000    
      total equity
    		356,000,000 147,000,000        271,000,000 145,000,000 260,000,000 433,000,000 253,000,000      605,000,000 655,000,000 546,000,000 790,000,000 1,136,000,000 2,560,000,000 2,688,000,000 2,779,000,000 2,815,000,000 3,237,000,000 3,558,000,000 4,523,000,000 5,944,000,000 5,422,000,000 4,029,000,000 3,994,000,000 5,403,100,000 6,464,700,000 5,061,190,000    
      total liabilities and equity
    		26,824,000,000 27,266,000,000        25,503,000,000 25,445,000,000 25,686,000,000 26,298,000,000 28,171,000,000      31,199,000,000 31,562,000,000 31,396,000,000 31,865,000,000 33,863,000,000 31,667,000,000 32,354,000,000 32,551,000,000 32,492,000,000 33,777,000,000 34,448,000,000 35,798,000,000 37,497,000,000 39,974,000,000 41,733,000,000 42,333,000,000 47,662,200,000 48,454,600,000 28,204,384,000    
      common shares, no par value, unlimited shares authorized, 369,749,489 and 367,843,058 issued and outstanding at june 30, 2025 and december 31, 2024, respectively
    		 10,510,000,000                                        
      deficit
    		                                         
      common shares, no par value, unlimited shares authorized, 369,539,455 and 367,843,058 issued and outstanding at march 31, 2025 and december 31, 2024, respectively
    		  10,508,000,000                                       
      total deficit
    		  -240,000,000 -322,000,000 -242,000,000 -227,000,000 -174,000,000        -141,000,000                           
      total liabilities and deficit
    		  26,421,000,000 26,523,000,000 26,540,000,000 26,495,000,000 26,913,000,000        29,090,000,000                           
      common shares, no par value, unlimited shares authorized, 367,843,058 and 365,238,917 issued and outstanding at december 31, 2024 and 2023, respectively
    		   10,490,000,000                                      
      common shares, no par value, unlimited shares authorized, 367,695,267 and 365,238,917 issued and outstanding at september 30, 2024 and december 31, 2023, respectively
    		    10,489,000,000                                     
      common shares, no par value, unlimited shares authorized, 366,985,967 and 365,238,917 issued and outstanding at june 30, 2024 and december 31, 2023, respectively
    		     10,483,000,000                                    
      common shares, no par value, unlimited shares authorized, 366,674,264 and 365,238,917 issued and outstanding at march 31, 2024 and december 31, 2023, respectively
    		      10,480,000,000                                   
      restricted cash and other settlement deposits
    		       15,000,000    27,000,000 11,000,000 1,220,000,000 1,211,000,000 1,537,000,000                          
      (deficit) equity
    		                                         
      common shares, no par value, unlimited shares authorized, 365,238,917 and 361,898,846 issued and outstanding at december 31, 2023 and 2022, respectively
    		       10,423,000,000                                  
      total (deficit) equity
    		       -82,000,000 -235,000,000       -34,000,000 -135,000,000 -611,000,000 -124,000,000                       
      total liabilities and (deficit) equity
    		       27,350,000,000 27,064,000,000       29,202,000,000 29,252,000,000 30,042,000,000 30,197,000,000                       
      common shares, no par value, unlimited shares authorized, 365,043,317 and 361,898,846 issued and outstanding at september 30, 2023 and december 31, 2022, respectively
    		        10,420,000,000                                 
      common shares, no par value, unlimited shares authorized, 364,063,514 and 361,898,846 issued and outstanding at june 30, 2023 and december 31, 2022, respectively
    		         10,412,000,000                                
      common shares, no par value, unlimited shares authorized, 363,607,062 and 361,898,846 issued and outstanding at march 31, 2023 and december 31, 2022, respectively
    		          10,405,000,000                               
      common shares, no par value, unlimited shares authorized, 361,898,846 and 359,405,748 issued and outstanding at december 31, 2022 and 2021, respectively
    		           10,391,000,000                              
      common shares, no par value, unlimited shares authorized, 361,781,292 and 359,405,748 issued and outstanding at september 30, 2022 and december 31, 2021, respectively
    		            10,387,000,000                             
      common shares, no par value, unlimited shares authorized, 361,571,921 and 359,405,748 issued and outstanding at june 30, 2022 and december 31, 2021, respectively
    		             10,380,000,000                            
      common shares, no par value, unlimited shares authorized, 361,331,665 and 359,405,748 issued and outstanding at march 31, 2022 and december 31, 2021, respectively
    		              10,373,000,000                           
      common shares, no par value, unlimited shares authorized, 359,405,748 and 355,422,347 issued and outstanding at december 31, 2021 and 2020, respectively
    		               10,317,000,000                          
      total bausch health companies inc. shareholders’ (deficit) equity
    		               -106,000,000 -204,000,000 -687,000,000 -197,000,000                       
      /s/ joseph c. papa
    		                                         
      joseph c. papa
    		                                         
      chief executive officer
    		                                         
      common shares, no par value, unlimited shares authorized, 359,154,635 and 355,422,347 issued and outstanding at september 30, 2021 and december 31, 2020, respectively
    		                10,312,000,000                         
      common shares, no par value, unlimited shares authorized, 358,653,899 and 355,422,347 issued and outstanding at june 30, 2021 and december 31, 2020, respectively
    		                 10,300,000,000                        
      common shares, no par value, unlimited shares authorized, 358,104,438 and 355,422,347 issued and outstanding at march 31, 2021 and december 31, 2020, respectively
    		                  10,289,000,000                       
      current portion of long-term debt and other
    		                     1,000,000 4,000,000 1,234,000,000 100,000,000 56,000,000 257,000,000 228,000,000 298,000,000 230,000,000 2,000,000 209,000,000 925,000,000 813,000,000        
      common shares, no par value, unlimited shares authorized, 355,422,347 and 352,562,636 issued and outstanding at december 31, 2020 and 2019, respectively
    		                   10,227,000,000                      
      total bausch health companies inc. shareholders’ equity
    		                   535,000,000 587,000,000 474,000,000 719,000,000 1,063,000,000 2,482,000,000 2,601,000,000 2,693,000,000 2,733,000,000 3,153,000,000 3,467,000,000            
      common shares, no par value, unlimited shares authorized, 355,026,950 and 352,562,636 issued and outstanding at september 30, 2020 and december 31, 2019, respectively
    		                    10,219,000,000                     
      common shares, no par value, unlimited shares authorized, 354,927,516 and 352,562,636 issued and outstanding at june 30, 2020 and december 31, 2019, respectively
    		                     10,217,000,000                    
      common shares, no par value, unlimited shares authorized, 354,579,990 and 352,562,636 issued and outstanding at march 31, 2020 and december 31, 2019, respectively
    		                      10,209,000,000                   
      common shares, no par value, unlimited shares authorized, 352,562,636 and 349,871,102 issued and outstanding at december 31, 2019 and 2018, respectively
    		                       10,172,000,000                  
      common shares, no par value, unlimited shares authorized, 352,387,430 and 349,871,102 issued and outstanding at september 30, 2019 and december 31, 2018, respectively
    		                        10,168,000,000                 
      common shares, no par value, unlimited shares authorized, 352,248,896 and 349,871,102 issued and outstanding at june 30, 2019 and december 31, 2018, respectively
    		                         10,165,000,000                
      common shares, no par value, unlimited shares authorized, 351,873,984 and 349,871,102 issued and outstanding at march 31, 2019 and december 31, 2018, respectively
    		                          10,151,000,000               
      common shares, no par value, unlimited shares authorized, 349,871,102 and 348,708,567 issued and outstanding at december 31, 2018 and 2017, respectively
    		                           10,121,000,000              
      common shares, no par value, unlimited shares authorized, 349,754,139 and 348,708,567 issued and outstanding at september 30, 2018 and december 31, 2017, respectively
    		                            10,117,000,000             
      common shares, no par value, unlimited shares authorized, 349,600,960 and 348,708,567 issued and outstanding at june 30, 2018 and december 31, 2017, respectively
    		                             10,114,000,000            
      common shares, no par value, unlimited shares authorized, 349,219,074 and 348,708,567 issued and outstanding at march 31, 2018 and december 31, 2017, respectively
    		                              10,103,000,000           
      total valeant pharmaceuticals international, inc. shareholders’ equity
    		                              4,424,000,000 5,849,000,000 5,327,000,000 3,931,000,000 3,893,000,000 5,295,900,000 6,342,300,000 4,949,113,000    
      current assets held for sale
    		                                16,000,000 77,000,000 240,000,000       
      non-current assets held for sale
    		                               12,000,000 718,000,000 709,000,000 1,401,000,000       
      current liabilities held for sale
    		                                 22,000,000 49,000,000       
      non-current liabilities held for sale
    		                                461,000,000  48,000,000       
      common shares, no par value, unlimited shares authorized, 348,708,567 and 347,821,606 issued and outstanding at december 31, 2017 and 2016, respectively
    		                               10,090,000,000          
      pension and other benefit liabilities
    		                                198,000,000 201,000,000 197,000,000 191,600,000 221,900,000 230,978,000    
      liabilities for uncertain tax positions
    		                                265,000,000 258,000,000 253,000,000 116,300,000 109,300,000 159,673,000 105,766,000 99,544,000 95,945,000 
      common shares, no par value, unlimited shares authorized, 348,582,556 and 347,821,606 issued and outstanding at september 30, 2017 and december 31, 2016, respectively
    		                                10,086,000,000         
      common shares, no par value, unlimited shares authorized, 348,516,280 and 347,821,606
    		                                         
      issued and outstanding at june 30, 2017 and december 31, 2016, respectively
    		                                 10,085,000,000        
      common shares, no par value, unlimited shares authorized, 347,860,891 and 347,821,606
    		                                         
      issued and outstanding at march 31, 2017 and december 31, 2016, respectively
    		                                  10,041,000,000       
      other long-term assets
    		                                   219,400,000 236,100,000 241,952,000 199,436,000 97,469,000 89,511,000 
      long-term debt
    		                                   30,773,200,000 30,176,300,000 17,043,750,000 10,447,230,000 7,422,558,000 7,356,021,000 
      other long-term liabilities
    		                                   168,700,000 209,100,000 163,979,000 161,711,000 123,502,000 123,024,000 
      common shares, no par value, unlimited shares authorized, 343,030,673 and
    		                                         
      342,926,531 issued and outstanding at june 30, 2016 and december 31, 2015, respectively
    		                                   9,914,900,000      
      common shares, no par value, unlimited shares authorized, 343,094,009 and
    		                                         
      334,402,964 issued and outstanding at september 30, 2015 and december 31, 2014, respectively
    		                                    9,899,600,000     
      accounts receivable
    		                                     1,643,148,000 1,127,006,000 805,010,000 611,204,000 
      assets held for sale
    		                                     53,457,000 54,400,000 9,925,000 28,203,000 
      accrued liabilities and other current liabilities
    		                                     1,889,460,000 1,035,007,000 634,722,000 600,657,000 
      common shares, no par value, unlimited shares authorized, 332,757,906 and
    		                                         
      303,861,272 issued and outstanding at september 30, 2013 and december 31, 2012, respectively
    		                                     8,260,010,000    
      shareholders’ equity
    		                                         
      common shares, no par value, unlimited shares authorized, 332,455,182 and
    		                                         
      303,861,272 issued and outstanding at june 30, 2013 and december 31, 2012, respectively
    		                                      8,250,192,000   
      total shareholders’ equity
    		                                      5,702,529,000 3,785,182,000  
      total liabilities and shareholders’ equity
    		                                      19,782,258,000 14,146,208,000  
      marketable securities
    		                                         
      income taxes payable
    		                                       10,208,000 15,537,000 
      deferred revenue
    		                                       18,142,000 7,031,000 
      common shares, no par value, unlimited shares authorized, 302,899,442 and
    		                                         
      306,371,032 issued and outstanding at september 30, 2012 and december 31, 2011, respectively
    		                                       5,916,671,000  
      shareholders' equity
    		                                         
      common shares, no par value, unlimited shares authorized, 302,052,589 and
    		                                         
      306,371,032 issued and outstanding at june 30, 2012 and december 31, 2011, respectively
    		                                        5,885,225,000 
      total shareholders' equity
    		                                        3,695,431,000 
      total liabilities and shareholders' equity
    		                                        14,019,820,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.